Leading scientific researchers from the University of Oxford have said that the antiviral medication hydroxychloroquine is being ‘discarded prematurely’ and could still have benefit against COVID-19.
The experimental vaccine, known as ChAdOx1 nCoV-19, is one of the front-runners in the global race to provide protection against the new coronavirus causing the COVID-19 pandemic.